Vectorious Medical Technologies has raised cash to trial an implant for monitoring left atrial pressure in congestive heart failure patients, Globes reports. The series B round will fund a device the ...

(MENAFN- PR Newswire) TEL AVIV, Israel, July 16, 2024 /PRNewswire/ -- A patient in Cincinnati has become the first in the United States to receive an innovative system that enables remote monitoring ...

TEL AVIV, Israel--(BUSINESS WIRE)--Vectorious Medical Technologies Ltd., today announced that it has enrolled the first six patients in the VECTOR-HF II Study, which will evaluate the V-LAP System’s ...

Hillel's Tech Corner: Vectorious - Taking technology to heart. Literally. The Vectorious team, which is now more than 30 members strong, has successfully implanted in-heart micro computers in multiple ...

- Company Continuing to Develop its Groundbreaking CHF (Congestive Heart Failure) Monitoring System Toward 1 st-In-Man Trial - "We are gratified to close this major financing round, a vote of ...

TEL AVIV, Israel, July 8, 2024 /PRNewswire/ -- Vectorious Medical Technologies Ltd. announces the publication of a breakthrough pilot clinical study, which evaluated the V-LAP system and a novel ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by ...

TEL AVIV, Israel--(BUSINESS WIRE)--Vectorious Medical Technologies Ltd., an innovator in implantable hemodynamic monitoring in heart failure (HF), today announced results of VECTOR-HF I, a ...

Edwards Lifesciences Corp. fully acquired Vectorious Medical Technologies Ltd. for $497 million, following a series of investments in the heart failure technology company over the last five years.